Household goods conglomerate Reckitt Benckiser has issued a stark warning over the potential financial repercussions of the ongoing Iran war, highlighting that elevated oil prices could inflate costs by as much as £150 million and dampen consumer demand throughout 2026.
Substantial Cost Pressures from Oil Price Surge
The company, known for brands like Dettol and Durex, disclosed that if oil prices persist at 110 US dollars per barrel (approximately £81.33) for the entirety of 2026, it could face additional expenses ranging from £130 million to £150 million. This projection stems directly from the geopolitical tensions in the Middle East, which have driven commodity prices higher.
Reckitt described this potential cost increase as a "manageable level," indicating plans to mitigate the impact through strategic measures. These include enhancing supply chain flexibility and adjusting pricing structures to absorb the financial strain without severely disrupting operations.
Consumer Demand Under Threat
Beyond direct costs, the firm expressed concerns about the broader economic fallout. It noted that sustained high commodity prices could squeeze household budgets, leading to a noticeable decline in consumer demand. While forecasting remains challenging, Reckitt anticipates that prolonged price elevations would inevitably affect purchasing behavior across its product lines.
Mixed Financial Performance in First Quarter
In its latest financial update, Reckitt reported a modest 0.6% increase in like-for-like revenues for the first quarter. This growth was primarily driven by higher product prices, which offset a 2% drop in sales volume. However, the core business, excluding the Mead Johnson Nutrition division, experienced a sharp slowdown, with growth falling to 1.3% from 5.9% in the previous quarter.
Several factors contributed to this deceleration, including a weak global cold and flu season, difficult trading conditions in Europe, and disruptions linked to the Middle East conflict. European sales alone declined by 4.2% during the period.
Profit Margins and Future Outlook
The company warned that profit margins are likely to contract in the first half of the year, partly due to the cost pressures from the Iran war. However, it expects stronger profitability in the second half to counterbalance this effect. Despite the challenges, Reckitt reaffirmed its full-year guidance, projecting like-for-like net sales growth of 4% to 5%.
Chief Executive Kris Licht emphasized confidence in the company's trajectory, stating, "We maintain our like-for-like net revenue guidance for 2026. This will be driven by sequential growth from our market-leading Powerbrands, as the season resets and we continue to launch superior innovations including Mucinex 12-hour Cold and Fever, improved performance in Europe and continued strong growth across China, India and non-seasonal North America."
Reckitt's cautionary statements underscore the interconnectedness of global conflicts and corporate economics, as firms navigate uncertain terrain shaped by geopolitical events and fluctuating market dynamics.
